What We're Reading: Page 248
Industry reads hand-picked by our editors
Mar 18, 2019
-
The Wall Street Journal
New Guidelines Advise Against Aspirin to Prevent Heart Disease
-
Financial Times
AstraZeneca places digital tech at core of blueprint for growth
-
Axios
Competition doesn't always drive down drug prices
-
The New York Times
Did Your Doctor Disappear Without a Word? A Noncompete Clause Could Be the Reason
Mar 15, 2019
Mar 14, 2019
Mar 13, 2019
Mar 12, 2019
Mar 11, 2019
-
The New York Times
An unvaccinated boy got tetanus. His Oregon hospital stay: 57 days and $800,000.
-
The Wall Street Journal
Bureau of prisons opens new investigation into Martin Shkreli
-
BioCentury
Top-down solution to the U.K. Orkambi debacle
-
Xconomy
The Life, Troubles, and Celgene Legacy of Deal Guru George Golumbeski
Mar 08, 2019
-
Science
The war on 'prediabetes' could be a boon for pharma — but is it good medicine?
-
The Wall Street Journal
Trump Administration Weighs Publicizing Secret Rates Hospitals and Doctors Negotiate With Insurers
-
Evaluate
Off-the-shelf approaches keep cell therapy investors keen
-
Bloomberg
African pharma tycoon Saad falls from grace as Aspen plunges
Previous
